Synthesis and characterization of stearyl protamine and investigation of their complexes with DNA for gene delivery.

A novel gene carrier, stearyl protamine (SP) was synthesized by the reaction of natural protamine with an N-hydroxysuccinimide (NHS) ester of stearic acid. This SP was characterized by FT-IR, stearyl content measurement and dynamic light scattering (DLS). Then, the SP was evaluated as a gene delivery carrier. The SP with higher stearyl group content (SP3) can self-assemble into aggregates with an average diameter of ca. 110 nm in water and has relatively higher in vitro gene transfection efficiency than protamine and SP with lower stearyl group content. A possible mechanism is proposed for the formation of complex of SP/DNA. The SP also shows a low cytotoxicity similar to protamine.

[1]  A. Zimmer,et al.  Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  J. A. Hoffmann,et al.  Purification and analysis of the major components of chum salmon protamine contained in insulin formulations using high-performance liquid chromatography. , 1990, Protein expression and purification.

[3]  Shiroh Futaki,et al.  A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids. , 2005, International journal of pharmaceutics.

[4]  E Marshall,et al.  Gene Therapy Death Prompts Review of Adenovirus Vector , 1999, Science.

[5]  E. Schacht,et al.  Structure-activity relationships of poly(L-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[6]  R. Balhorn,et al.  Protamine-induced condensation and decondensation of the same DNA molecule. , 1999, Science.

[7]  A. Zimmer,et al.  Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[8]  S. Carotta,et al.  Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo , 2001, The journal of gene medicine.

[9]  C. R. Middaugh,et al.  Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. , 2005, Journal of pharmaceutical sciences.

[10]  Steven C. Ghivizzani,et al.  Viral vectors for gene therapy. , 1998, Pharmacology & therapeutics.

[11]  S. W. Kim,et al.  Development of biomaterials for gene therapy. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  조종수,et al.  Galactosylated Chitosan-DNA Nanoparticles Prepared Using Water-Soluble Chitosan As a Gene Carrier , 2001 .

[13]  A. Schätzlein,et al.  Dendrimers in gene delivery. , 2005, Advanced drug delivery reviews.

[14]  P. Pfeffer,et al.  Protamine sulfate protects exogenous DNA against nuclease degradation but is unable to improve the efficiency of bovine sperm mediated transgenesis. , 2006, Animal reproduction science.

[15]  Sung Wan Kim,et al.  Current status of polymeric gene delivery systems. , 2006, Advanced drug delivery reviews.

[16]  H. Temin.  Safety considerations in somatic gene therapy of human disease with retrovirus vectors. , 1990, Human gene therapy.

[17]  Shiroh Futaki,et al.  Octaarginine-modified multifunctional envelope-type nano device for siRNA. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Ralph Weissleder,et al.  Protamine as an efficient membrane-translocating peptide. , 2005, Bioconjugate chemistry.

[19]  J. Birchall,et al.  Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes. , 2000, International journal of pharmaceutics.

[20]  Sally Lehrman,et al.  Virus treatment questioned after gene therapy death , 1999, Nature.

[21]  A. Göpferich,et al.  Polyethylenimine-based non-viral gene delivery systems. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  H Harashima,et al.  Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation , 2004, Gene Therapy.

[23]  H. Gao,et al.  Synthesis of a novel series of cationic lipids that can act as efficient gene delivery vehicles through systematic heterocyclic substitution of cholesterol derivatives , 2001, Gene Therapy.

[24]  M. D. Brown,et al.  Gene delivery with synthetic (non viral) carriers. , 2001, International journal of pharmaceutics.

[25]  K. Ewert,et al.  Efficient synthesis and cell-transfection properties of a new multivalent cationic lipid for nonviral gene delivery. , 2002, Journal of medicinal chemistry.

[26]  D. Lu,et al.  In Vitro Gene Transfection in Human Glioma Cells Using a Novel and Less Cytotoxic Artificial Lipoprotein Delivery System , 2003, Pharmaceutical Research.

[27]  Z. Haque,et al.  Lipophilization of soybean glycinin: Covalent attachment to long chain fatty acids. , 1982 .

[28]  W. Godbey,et al.  Viral vectors for gene delivery in tissue engineering. , 2006, Advanced drug delivery reviews.